compound semaglutide legal Compounded semaglutide: What should patients know? The FDA Warns of the

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

See who qualifies

Up to 64% of GLP-1 patients discontinue therapy

Experiencing mucus in stool while taking tirzepatide

Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.

Stay on track with personalised goals, protein targets & healthy habits.